Sulfisoxazole

CAS No. 127-69-5

Sulfisoxazole( NSC 13120 | NSC 33807 | NSC 38588 | NSC 683536 | Sulfafurazole )

Catalog No. M11150 CAS No. 127-69-5

Sulfisoxazole, an endothelin receptor antagonist, is a sulfonamide antibacterial with an oxazole substituent.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
50MG 39 In Stock
100MG 56 In Stock
200MG 73 In Stock
500MG 105 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Sulfisoxazole
  • Note
    Research use only, not for human use.
  • Brief Description
    Sulfisoxazole, an endothelin receptor antagonist, is a sulfonamide antibacterial with an oxazole substituent.
  • Description
    Sulfisoxazole, an endothelin receptor antagonist, is a sulfonamide antibacterial with an oxazole substituent.
  • In Vitro
    Western Blot Analysis Cell Line:MDA-MB-231 cell Concentration:100 μM Incubation Time:24 h Result:Reduced the expression of Rab27a.
  • In Vivo
    ——
  • Synonyms
    NSC 13120 | NSC 33807 | NSC 38588 | NSC 683536 | Sulfafurazole
  • Pathway
    Autophagy
  • Target
    Autophagy
  • Recptor
    DHPS
  • Research Area
    Infection
  • Indication
    ——

Chemical Information

  • CAS Number
    127-69-5
  • Formula Weight
    267.31
  • Molecular Formula
    C11H13N3O3S
  • Purity
    >98% (HPLC)
  • Solubility
    Ethanol: 2 mg/mL (7.48 mM); DMSO: 53 mg/mL (198.27 mM)
  • SMILES
    O=S(NC1=C(C)C(C)=NO1)(C2=CC=C(N)C=C2)=O
  • Chemical Name
    4-amino-N-(3,4-dimethylisoxazol-5-yl)benzenesulfonamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Jorgensen JH, et al. J Clin Microbiol. 2005 Jul;43(7):3162-7
molnova catalog
related products
  • EACC

    EACC selectively inhibits the translocation of autophagosome-specific SNARE Stx17 thereby blocking autophagosome-lysosome fusion.?

  • Glycycoumarin

    Glycycoumarin is an estrogen agonist, it shows moderate inhibitory effects against CYP1A2 and CYP2B6.

  • STO-609 acetate

    STO-609 acetate is selective, cell-permeable inhibitor of Ca2+-calmodulin-dependent protein kinase kinase (Ki: 80/15 ng/ml, for CaM-KKα/KKβ); competes for the ATP-binding site.